← Back to Search

Antiretroviral Agent

1 for Human Immunodeficiency Virus Infection

N/A
Waitlist Available
Led By Steven G. Deeks, MD
Research Sponsored by National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up thoughout study
Awards & highlights

Study Summary

Drug resistance may develop in HIV infected patients who take anti-HIV drugs, but most patients do well if they continue taking them. The purpose of this study is to test the effectiveness of a short, intensified course of anti-HIV drugs for controlling HIV infection in adults who have virus resistant to multiple drugs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout study
This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HIV viral load
Secondary outcome measures
Frequency of HIV-specific T cells

Side effects data

From 2007 Phase 4 trial • 142 Patients • NCT00326963
1%
Pneumonia primary atypical
1%
Sinusitis
1%
Cellulitis
1%
Pneumonia
1%
Sepsis
1%
Pneumocystis jiroveci Pneumonia
1%
Renal failure
1%
Asthma
1%
Dyspnoea
1%
Anaemia
1%
Upper Gastrointestinal haemorrhage
1%
Neutrophil count decreased
1%
Metabolic acidosis
1%
Myopathy steroid
1%
Erythema nodosum
100%
80%
60%
40%
20%
0%
Study treatment Arm
Enfuvirtide+PI+ARV's

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Participants will receive enfuvirtide for 6 months

Find a Location

Who is running the clinical trial?

National Institute of Allergy and Infectious Diseases (NIAID)Lead Sponsor
3,269 Previous Clinical Trials
5,481,449 Total Patients Enrolled
Steven G. Deeks, MDPrincipal InvestigatorDepartment of Medicine, University of California - San Francisco
1 Previous Clinical Trials
50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus
2003. "Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00102934.
All > Cte
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top